Clinical trial for a better treatment for mycetoma starts in Sudan

[Khartoum, Sudan – 19 June 2017]
First ever double-blind study for disease so neglected that it only recently was added to WHO list of neglected tropical diseases

The first-ever double-blind, randomized clinical trial for an effective treatment for the severely neglected disease mycetoma has enrolled its first patient at the Mycetoma Research Centre (MRC) in Khartoum, Sudan.

ECTMIH 2017

October 16-20, 2017
Antwerp, Belgium
DNDi presented on sleeping sickness, visceral leishmaniasis, mycetoma, and onchocerciasis.

Daiichi Sankyo announces collaborative research on drugs for neglected diseases

[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.

8th Trends in Medical Mycology

October 6-9, 2017
Belgrade, Serbia
Jean-Robert Ioset, Discovery Manager, and Benjamin Perry, Senior Discovery Manager – Open Innovation, presented posters at the meeting.

IMTechCon 2017

October 4-6, 2017
Chandigarh, India
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.